Hepatitis C Virus Stocks List

Recent Signals

Date Stock Signal Type
2021-08-04 BMY Stochastic Reached Overbought Strength
2021-08-04 BMY New 52 Week High Strength
2021-08-04 BMY Upper Bollinger Band Walk Strength
2021-08-04 ENTA Bollinger Band Squeeze Range Contraction
2021-08-04 ENTA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-08-04 INO 20 DMA Support Bullish
2021-08-04 INO 50 DMA Support Bullish
2021-08-04 INO Wide Range Bar Range Expansion
2021-08-04 INO Pocket Pivot Bullish Swing Setup
2021-08-04 INO Expansion Pivot Buy Setup Bullish Swing Setup
2021-08-04 INO Bollinger Band Squeeze Range Contraction
2021-08-04 IONS Stochastic Reached Overbought Strength
2021-08-04 IONS Bollinger Band Squeeze Range Contraction
2021-08-04 NNVC 1,2,3 Pullback Bullish Bullish Swing Setup
2021-08-04 NNVC Calm After Storm Range Contraction
2021-08-04 RGLS Bollinger Band Squeeze Range Contraction
2021-08-04 RGLS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-08-04 RGLS 20 DMA Support Bullish
2021-08-04 SCYX Bollinger Band Squeeze Range Contraction
2021-08-04 SCYX MACD Bearish Signal Line Cross Bearish
2021-08-04 SCYX 180 Bearish Setup Bearish Swing Setup
2021-08-04 VRTX 50 DMA Resistance Bearish
2021-08-04 VRTX 180 Bearish Setup Bearish Swing Setup
2021-08-04 VRTX 20 DMA Support Bullish
2021-08-04 VRTX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-08-04 VRTX Bollinger Band Squeeze Range Contraction

Hepatitis C Virus Stocks Recent News

Date Stock Title
Aug 4 IONS Ionis Pharmaceuticals, Inc. (IONS) CEO Brett Monia on Q2 2021 Results - Earnings Call Transcript
Aug 4 IONS Ionis Pharmaceuticals, inc (IONS) Q2 2021 Earnings Call Transcript
Aug 4 ENTA Enanta Pharma FQ3 2021 Earnings Preview
Aug 4 INO Is Inovio Stock A Buy After Dosing The First Person In A New Vaccine Test?
Aug 4 VRTX Here is Why Growth Investors Should Buy Vertex (VRTX) Now
Aug 4 VRTX Vertex names Stuart Arbuckle as chief operating officer
Aug 4 VRTX Vertex Appoints Stuart A. Arbuckle as Chief Operating Officer
Aug 4 IONS Ionis Pharmaceuticals (IONS) Reports Q2 Loss, Lags Revenue Estimates
Aug 4 INO INOVIO gets dosing underway in mid-stage INO-4700 MERS study
Aug 4 INO INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease
Aug 4 IONS Ionis Pharmaceuticals EPS in-line, misses on revenue
Aug 4 IONS Ionis reports second quarter 2021 financial results and recent business achievements
Aug 3 RGLS Regulus Therapeutics Announces Timing for Second Quarter 2021 Financial Results Webcast and Conference Call
Aug 3 IONS Ionis Pharmaceuticals Q2 2021 Earnings Preview
Aug 3 BMY Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland
Aug 3 VRTX Rising P/E: A Trick to Land on 5 Winning Stocks
Aug 3 RGLS The Read On Regulus Therapeutics
Aug 2 INO Analysts Estimate Inovio Pharmaceuticals (INO) to Report a Decline in Earnings: What to Look Out for
Aug 2 IONS Ionis provides enrollment update for Novartis' late-stage pelacarsen study
Aug 2 IONS Lp(a) HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events

Hepatitis C virus (HCV) is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. Hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans.

More about Hepatitis C Virus
Browse All Tags